These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Neurology; 2004 Jun 08; 62(11):1977-83. PubMed ID: 15184600 [Abstract] [Full Text] [Related]
25. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Tsang SW, Lai MK, Kirvell S, Francis PT, Esiri MM, Hope T, Chen CP, Wong PT. Neurobiol Aging; 2006 Sep 08; 27(9):1216-23. PubMed ID: 16129514 [Abstract] [Full Text] [Related]
30. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease. Rodriguez MJ, Potter E, Shen Q, Barker W, Greig-Custo M, Agron J, Loewenstein D, Duara R. Alzheimers Dement; 2012 May 08; 8(3):211-8. PubMed ID: 22546353 [Abstract] [Full Text] [Related]
31. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Jellinger KA, Attems J. Acta Neuropathol; 2008 Apr 08; 115(4):427-36. PubMed ID: 18273624 [Abstract] [Full Text] [Related]
32. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies. Lemstra AW, de Beer MH, Teunissen CE, Schreuder C, Scheltens P, van der Flier WM, Sikkes SA. J Neurol Neurosurg Psychiatry; 2017 Feb 08; 88(2):113-118. PubMed ID: 27794030 [Abstract] [Full Text] [Related]
34. Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. Hansen LA, Daniel SE, Wilcock GK, Love S. J Neurol Neurosurg Psychiatry; 1998 May 08; 64(5):653-6. PubMed ID: 9598683 [Abstract] [Full Text] [Related]
35. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Barkhof F, Polvikoski TM, van Straaten EC, Kalaria RN, Sulkava R, Aronen HJ, Niinistö L, Rastas S, Oinas M, Scheltens P, Erkinjuntti T. Neurology; 2007 Oct 09; 69(15):1521-7. PubMed ID: 17923614 [Abstract] [Full Text] [Related]
37. Education, cognitive function, and severity of neuropathology in Alzheimer disease. Koepsell TD, Kurland BF, Harel O, Johnson EA, Zhou XH, Kukull WA. Neurology; 2008 May 06; 70(19 Pt 2):1732-9. PubMed ID: 18160675 [Abstract] [Full Text] [Related]
38. Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study. Roudil J, Deramecourt V, Dufournet B, Dubois B, Ceccaldi M, Duyckaerts C, Pasquier F, Lebouvier T, Brainbank Neuro-CEB Neuropathology Network. J Alzheimers Dis; 2018 May 06; 63(4):1317-1323. PubMed ID: 29758938 [Abstract] [Full Text] [Related]
39. Cognitive status correlates with neuropathologic stage in Parkinson disease. Braak H, Rüb U, Jansen Steur EN, Del Tredici K, de Vos RA. Neurology; 2005 Apr 26; 64(8):1404-10. PubMed ID: 15851731 [Abstract] [Full Text] [Related]
40. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. J Neuropathol Exp Neurol; 1997 Aug 26; 56(8):933-44. PubMed ID: 9258263 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]